392 related articles for article (PubMed ID: 33736701)
21. β-PIX is critical for transplanted mesenchymal stromal cell migration.
Koh SH; Huh YM; Noh MY; Kim HY; Kim KS; Lee ES; Ko HJ; Cho GW; Yoo AR; Song HT; Hwang S; Lee K; Haam S; Frank JA; Suh JS; Kim SH
Stem Cells Dev; 2012 Jul; 21(11):1989-99. PubMed ID: 22087847
[TBL] [Abstract][Full Text] [Related]
22. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1
Bursch F; Rath KJ; Sarikidi A; Böselt S; Kefalakes E; Osmanovic A; Thau-Habermann N; Klöß S; Köhl U; Petri S
J Tissue Eng Regen Med; 2019 Apr; 13(4):649-663. PubMed ID: 30811816
[TBL] [Abstract][Full Text] [Related]
24. Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases.
Kim SH; Oh KW; Jin HK; Bae JS
BMB Rep; 2018 Nov; 51(11):545-546. PubMed ID: 30463642
[TBL] [Abstract][Full Text] [Related]
25. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
[TBL] [Abstract][Full Text] [Related]
26. Functional Restoration of Amyotrophic Lateral Sclerosis Patient-Derived Mesenchymal Stromal Cells Through Inhibition of DNA Methyltransferase.
Oh YS; Kim SH; Cho GW
Cell Mol Neurobiol; 2016 May; 36(4):613-20. PubMed ID: 26210997
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis.
Hajivalili M; Pourgholi F; Kafil HS; Jadidi-Niaragh F; Yousefi M
Curr Stem Cell Res Ther; 2016; 11(1):41-50. PubMed ID: 26329483
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stem cell aggregation mediated by integrin α4/VCAM-1 after intrathecal transplantation in MCAO rats.
Ran Y; Dong Y; Li Y; Xie J; Zeng S; Liang C; Dai W; Tang W; Wu Y; Yu S
Stem Cell Res Ther; 2022 Oct; 13(1):507. PubMed ID: 36273220
[TBL] [Abstract][Full Text] [Related]
29. Preclinical studies of mesenchymal stem cells transplantation in amyotrophic lateral sclerosis: a systemic review and metaanalysis.
Zhou Q; Yuan M; Qiu W; Cao W; Xu R
Neurol Sci; 2021 Sep; 42(9):3637-3646. PubMed ID: 33433755
[TBL] [Abstract][Full Text] [Related]
30. Characterisation of mesenchymal stem cells from patients with amyotrophic lateral sclerosis.
Matejckova N; Zajicova A; Hermankova B; Kossl J; Bohacova P; Holan V; Javorkova E
J Clin Pathol; 2018 Aug; 71(8):735-742. PubMed ID: 29523587
[TBL] [Abstract][Full Text] [Related]
31. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
[TBL] [Abstract][Full Text] [Related]
32. Stem cell transplantation into the intraventricular space via an Ommaya reservoir in a patient with amyotrophic lateral sclerosis.
Baek W; Kim YS; Koh SH; Lim SW; Kim HY; Yi HJ; Kim H
J Neurosurg Sci; 2012 Sep; 56(3):261-3. PubMed ID: 22854595
[TBL] [Abstract][Full Text] [Related]
33. Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles.
Sobuś A; Baumert B; Litwińska Z; Gołąb-Janowska M; Stępniewski J; Kotowski M; Pius-Sadowska E; Kawa MP; Gródecka-Szwajkiewicz D; Peregud-Pogorzelski J; Dulak J; Nowacki P; Machaliński B
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702606
[TBL] [Abstract][Full Text] [Related]
34. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury.
Takahashi A; Nakajima H; Uchida K; Takeura N; Honjoh K; Watanabe S; Kitade M; Kokubo Y; Johnson WEB; Matsumine A
Cell Transplant; 2018 Jul; 27(7):1126-1139. PubMed ID: 29947256
[TBL] [Abstract][Full Text] [Related]
36. Optimal Therapeutic Strategy of Bone Marrow-Originated Autologous Mesenchymal Stromal/Stem Cells for ALS.
Kim SH; Oh KW; Noh MY; Kwon MS
Stem Cells Transl Med; 2024 Apr; 13(4):309-316. PubMed ID: 38244235
[TBL] [Abstract][Full Text] [Related]
37. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
[TBL] [Abstract][Full Text] [Related]
38. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
[TBL] [Abstract][Full Text] [Related]
39. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Zimmermann JA; McDevitt TC
Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects.
Rahbaran M; Zekiy AO; Bahramali M; Jahangir M; Mardasi M; Sakhaei D; Thangavelu L; Shomali N; Zamani M; Mohammadi A; Rahnama N
Cell Mol Biol Lett; 2022 Jul; 27(1):56. PubMed ID: 35842587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
